"Don’t wait to get the important care you need. At Ascension, we have changed the ways we provide care. In-person and virtual visits are available. When you need care, Ascension is committed to keeping you safe while you’re receiving it. Our hospitals and clinics have implemented safety precautions to protect our patients and our care teams. From screening our associates to rigorous cleaning and disinfecting procedures, we are balancing care with caution. Call to discuss the right option for your care and to learn more about specific safety and visitor guidelines."

During the past decade, Ascension Borgess Cancer Center conducted 59 clinical trials. In the 10-year time frame, 59 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 41 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ascension Borgess Cancer Center" #1 sponsor was "National Cancer Institute (NCI)" with 30 trials, followed by "Alliance for Clinical Trials in Oncology" with 9 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 8 trials sponsored, "SWOG Cancer Research Network" with 6 trials sponsored and "NRG Oncology" with 6 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ascension Borgess Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 28 trials as a collaborator, "Genentech, Inc." with 3 trials as a collaborator, "NRG Oncology" with 2 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator and "Bayer" with 1 trials as a collaborator. Other collaborators include 5 different institutions and companies that were collaborators in the rest 15 trials.

According to Clinical.Site data, the most researched conditions in "Ascension Borgess Cancer Center" are "Recurrent Lung Non-Small Cell Carcinoma" (4 trials), "Stage IIIB Lung Cancer AJCC v8" (4 trials), "Stage IV Lung Cancer AJCC v8" (4 trials), "Anatomic Stage II Breast Cancer AJCC v8" (3 trials) and "Clinical Stage III Cutaneous Melanoma AJCC v8" (3 trials). Many other conditions were trialed in "Ascension Borgess Cancer Center" in a lesser frequency.

Most popular intervention types in "Ascension Borgess Cancer Center" are "Drug" (45 trials), "Other" (30 trials), "Procedure" (28 trials), "Biological" (27 trials) and "Radiation" (5 trials). Other intervention types were less common.

The name of intervention was led by "Computed Tomography" (18 trials), "Biospecimen Collection" (17 trials), "Quality-of-Life Assessment" (17 trials), "Questionnaire Administration" (13 trials) and "Nivolumab" (12 trials). Other intervention names were less common.

The vast majority of trials in "Ascension Borgess Cancer Center" are 51 trials for "All" genders, 6 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Ascension Borgess Cancer Center". undefined are not yet recruiting, 44 are recruiting, 10 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Ascension Borgess Cancer Center, 4 suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Ascension Borgess Cancer Center, 0 "Phase 1" clinical trials were conducted, 29 "Phase 2" clinical trials and 30 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".